Brief description of study

If you or your child have cancer that has become worse following treatment, or because no standard therapy exists for your type of cancer, you or your child may qualify to participate in The Pediatric MATCH (Molecular Analysis for Therapy Choice) study. This study will match targeted agents with specific molecular changes identified using genomic sequencing technologies in refractory/recurrent tumors from children and adolescents with cancer. The main purpose of this study is to learn how well tumors that have specific genetic changes (mutations) respond to drugs that target those changes. This combination of a tumor with a mutation and a drug that aims at that mutation is called a match."

Clinical Study Identifier: s17-01214
ClinicalTrials.gov Identifier: NCT03155620
Principal Investigator: Sharon L Gardner.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.